Evaluation of fetal and maternal vancomycin-induced kidney injury during pregnancy in a rat model

Medha D. Joshi, Gwendolyn M. Pais, Jack Chang, Khrystyna Hlukhenka, Sean N. Avedissian, Anil Gulati, Walter C. Prozialeck, Peter C. Lamar, Zhong Zhang, Marc H. Scheetz, Brooke Griffin

Research output: Contribution to journalArticle

Abstract

Previous literature suggests that maternal vancomycin crosses the placental barrier to the fetus. Further, early animal studies indicated that kidney injury was not observed in the progeny. These studies were conducted prior to the availability of sensitive biomarkers for kidney injury. Therefore, a previous finding of no renal damage to the infant may be misleading. Vancomycin was administered intravenously to pregnant rats at a dose of 250 mg/kg of body weight/day (N = 6 per trimester) on three consecutive gestational days (GD) during trimesters 1, 2, and 3 (T1, T2, and T3, respectively) in three independent cohorts. The dams carried to term and delivered vaginally on GD 21. Kidneys were harvested from dams and pups and homogenized. Samples were prepared by protein precipitation and injected in a liquid chromatography tandem mass spectrometer, and vancomycin was quantified. The kidney tissue homogenate from dams and pups were analyzed for kidney injury molecule-1 (KIM-1). As trimesters progressed, the quantity of vancomycin increased linearly in the kidneys of both rat dams and pups (P < 0.0001 for T1 and T3, P < 0.0001 for T2 and T3, and P < 0.0001 for T3 and T3 control for both rat dams and pups). KIM-1 concentrations in pup kidneys were significantly higher when dams were administered vancomycin in trimesters 1 (P = 0.0001) and 2 (P = 0.0024) than in controls in trimester 3. Data demonstrate persistence of vancomycin in maternal and rat pup kidneys in all three trimesters of pregnancy with associated damage to the kidney, as indicated by expression of KIM-1.

Original languageEnglish (US)
Article numbere00761-19
JournalAntimicrobial Agents and Chemotherapy
Volume63
Issue number10
DOIs
StatePublished - Jan 1 2019

Fingerprint

Vancomycin
Mothers
Kidney
Pregnancy
Wounds and Injuries
Pregnancy Trimesters
Liquid Chromatography
Fetus
Biomarkers
Body Weight

Keywords

  • KIM-1
  • Maternal fetal exposure
  • Pregnancy
  • Rat model
  • Trimester
  • Vancomycin

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Evaluation of fetal and maternal vancomycin-induced kidney injury during pregnancy in a rat model. / Joshi, Medha D.; Pais, Gwendolyn M.; Chang, Jack; Hlukhenka, Khrystyna; Avedissian, Sean N.; Gulati, Anil; Prozialeck, Walter C.; Lamar, Peter C.; Zhang, Zhong; Scheetz, Marc H.; Griffin, Brooke.

In: Antimicrobial Agents and Chemotherapy, Vol. 63, No. 10, e00761-19, 01.01.2019.

Research output: Contribution to journalArticle

Joshi, MD, Pais, GM, Chang, J, Hlukhenka, K, Avedissian, SN, Gulati, A, Prozialeck, WC, Lamar, PC, Zhang, Z, Scheetz, MH & Griffin, B 2019, 'Evaluation of fetal and maternal vancomycin-induced kidney injury during pregnancy in a rat model', Antimicrobial Agents and Chemotherapy, vol. 63, no. 10, e00761-19. https://doi.org/10.1128/AAC.00761-19
Joshi, Medha D. ; Pais, Gwendolyn M. ; Chang, Jack ; Hlukhenka, Khrystyna ; Avedissian, Sean N. ; Gulati, Anil ; Prozialeck, Walter C. ; Lamar, Peter C. ; Zhang, Zhong ; Scheetz, Marc H. ; Griffin, Brooke. / Evaluation of fetal and maternal vancomycin-induced kidney injury during pregnancy in a rat model. In: Antimicrobial Agents and Chemotherapy. 2019 ; Vol. 63, No. 10.
@article{fac5616292e04f52a4e15125c5aff9c4,
title = "Evaluation of fetal and maternal vancomycin-induced kidney injury during pregnancy in a rat model",
abstract = "Previous literature suggests that maternal vancomycin crosses the placental barrier to the fetus. Further, early animal studies indicated that kidney injury was not observed in the progeny. These studies were conducted prior to the availability of sensitive biomarkers for kidney injury. Therefore, a previous finding of no renal damage to the infant may be misleading. Vancomycin was administered intravenously to pregnant rats at a dose of 250 mg/kg of body weight/day (N = 6 per trimester) on three consecutive gestational days (GD) during trimesters 1, 2, and 3 (T1, T2, and T3, respectively) in three independent cohorts. The dams carried to term and delivered vaginally on GD 21. Kidneys were harvested from dams and pups and homogenized. Samples were prepared by protein precipitation and injected in a liquid chromatography tandem mass spectrometer, and vancomycin was quantified. The kidney tissue homogenate from dams and pups were analyzed for kidney injury molecule-1 (KIM-1). As trimesters progressed, the quantity of vancomycin increased linearly in the kidneys of both rat dams and pups (P < 0.0001 for T1 and T3, P < 0.0001 for T2 and T3, and P < 0.0001 for T3 and T3 control for both rat dams and pups). KIM-1 concentrations in pup kidneys were significantly higher when dams were administered vancomycin in trimesters 1 (P = 0.0001) and 2 (P = 0.0024) than in controls in trimester 3. Data demonstrate persistence of vancomycin in maternal and rat pup kidneys in all three trimesters of pregnancy with associated damage to the kidney, as indicated by expression of KIM-1.",
keywords = "KIM-1, Maternal fetal exposure, Pregnancy, Rat model, Trimester, Vancomycin",
author = "Joshi, {Medha D.} and Pais, {Gwendolyn M.} and Jack Chang and Khrystyna Hlukhenka and Avedissian, {Sean N.} and Anil Gulati and Prozialeck, {Walter C.} and Lamar, {Peter C.} and Zhong Zhang and Scheetz, {Marc H.} and Brooke Griffin",
year = "2019",
month = "1",
day = "1",
doi = "10.1128/AAC.00761-19",
language = "English (US)",
volume = "63",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Evaluation of fetal and maternal vancomycin-induced kidney injury during pregnancy in a rat model

AU - Joshi, Medha D.

AU - Pais, Gwendolyn M.

AU - Chang, Jack

AU - Hlukhenka, Khrystyna

AU - Avedissian, Sean N.

AU - Gulati, Anil

AU - Prozialeck, Walter C.

AU - Lamar, Peter C.

AU - Zhang, Zhong

AU - Scheetz, Marc H.

AU - Griffin, Brooke

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Previous literature suggests that maternal vancomycin crosses the placental barrier to the fetus. Further, early animal studies indicated that kidney injury was not observed in the progeny. These studies were conducted prior to the availability of sensitive biomarkers for kidney injury. Therefore, a previous finding of no renal damage to the infant may be misleading. Vancomycin was administered intravenously to pregnant rats at a dose of 250 mg/kg of body weight/day (N = 6 per trimester) on three consecutive gestational days (GD) during trimesters 1, 2, and 3 (T1, T2, and T3, respectively) in three independent cohorts. The dams carried to term and delivered vaginally on GD 21. Kidneys were harvested from dams and pups and homogenized. Samples were prepared by protein precipitation and injected in a liquid chromatography tandem mass spectrometer, and vancomycin was quantified. The kidney tissue homogenate from dams and pups were analyzed for kidney injury molecule-1 (KIM-1). As trimesters progressed, the quantity of vancomycin increased linearly in the kidneys of both rat dams and pups (P < 0.0001 for T1 and T3, P < 0.0001 for T2 and T3, and P < 0.0001 for T3 and T3 control for both rat dams and pups). KIM-1 concentrations in pup kidneys were significantly higher when dams were administered vancomycin in trimesters 1 (P = 0.0001) and 2 (P = 0.0024) than in controls in trimester 3. Data demonstrate persistence of vancomycin in maternal and rat pup kidneys in all three trimesters of pregnancy with associated damage to the kidney, as indicated by expression of KIM-1.

AB - Previous literature suggests that maternal vancomycin crosses the placental barrier to the fetus. Further, early animal studies indicated that kidney injury was not observed in the progeny. These studies were conducted prior to the availability of sensitive biomarkers for kidney injury. Therefore, a previous finding of no renal damage to the infant may be misleading. Vancomycin was administered intravenously to pregnant rats at a dose of 250 mg/kg of body weight/day (N = 6 per trimester) on three consecutive gestational days (GD) during trimesters 1, 2, and 3 (T1, T2, and T3, respectively) in three independent cohorts. The dams carried to term and delivered vaginally on GD 21. Kidneys were harvested from dams and pups and homogenized. Samples were prepared by protein precipitation and injected in a liquid chromatography tandem mass spectrometer, and vancomycin was quantified. The kidney tissue homogenate from dams and pups were analyzed for kidney injury molecule-1 (KIM-1). As trimesters progressed, the quantity of vancomycin increased linearly in the kidneys of both rat dams and pups (P < 0.0001 for T1 and T3, P < 0.0001 for T2 and T3, and P < 0.0001 for T3 and T3 control for both rat dams and pups). KIM-1 concentrations in pup kidneys were significantly higher when dams were administered vancomycin in trimesters 1 (P = 0.0001) and 2 (P = 0.0024) than in controls in trimester 3. Data demonstrate persistence of vancomycin in maternal and rat pup kidneys in all three trimesters of pregnancy with associated damage to the kidney, as indicated by expression of KIM-1.

KW - KIM-1

KW - Maternal fetal exposure

KW - Pregnancy

KW - Rat model

KW - Trimester

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=85072600444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072600444&partnerID=8YFLogxK

U2 - 10.1128/AAC.00761-19

DO - 10.1128/AAC.00761-19

M3 - Article

C2 - 31332061

AN - SCOPUS:85072600444

VL - 63

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 10

M1 - e00761-19

ER -